Top-Down Therapy: Is the Evidence Strong Enough?

Publisher： Karger

E-ISSN： 1421-9875|27|3|306-311

ISSN： 0257-2753

Source： Digestive Diseases, Vol.27, Iss.3, 2009-09, pp. : 306-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medical Therapy for Crohn’s Disease: Top-Down or Step-Up?

By  

Digestive Diseases, Vol. 25, Iss. 3, 2007-09 ,pp. : 260-266

Karger

Access to resources Recommend Favorite

Top-Down or Step-Up Treatment in Crohn's Disease?

By  

Digestive Diseases, Vol. 31, Iss. 1, 2013-06 ,pp. : 83-90

Karger

Access to resources Recommend Favorite

Factors That Modulate Neurogenesis: A Top-Down Approach

By  

Brain, Behavior and Evolution, Vol. 87, Iss. 3, 2016-08 ,pp. : 184-190

Karger

Access to resources Recommend Favorite

Augmentation Therapy for Alpha-1 Antitrypsin Deficiency—Not Enough Evidence to Support its Use Yet!

By McCarthy Cormac   Dimitrov Borislav D.  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 7, Iss. 3, 2010-05 ,pp. : 234-234

Informa Healthcare

Access to resources Recommend Favorite

Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model

By Stasi Cristina  

Journal of Gastroenterology, Vol. 47, Iss. 11, 2012-11 ,pp. : 1177-1185

Springer Publishing Company

Access to resources Recommend Favorite